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Effects of a combretastatin A4 analogous chalcone and its

Pt
Introduction
Angiogenesis plays an essential role in the development and growth of solid tumours. The tumoural vascular network is characterised by peculiar irregularities and thus has been identified early on as a promising drug target. Vascular disrupting agents (VDAs) have been intensively investigated and some already went on clinical trials, mostly as combination regimens with DNA-targeting drugs [2, 3] . The majority of VDAs show a pronounced affinity for tubulin and interfere with the delicate mitotic machinery of dynamic microtubule formation and destruction. The microtubular cytoskeletal fibres are crucial to mitosis and cell division, for the maintenance of cell shape and in the transport of vesicles [4] . Moreover, they
are essential structural components of dendrites. In the brain, the formation of dendrites is dependent on neural activity and is mediated in part by the modulation of mictrotubule stability [5] . A good deal of the recently published VDAs are synthetic variants of longknown natural tubulin binders, e.g., combretastatin A4 (CA4) which specifically binds to the colchicine binding site of tubulin and exhibits distinct anticancer activity in vitro and in vivo [6] . Structurally related are trimethoxyphenyl chalcones [7] . The molecular mechanism of their interference with microtubules and their vascular disrupting effect is not fully understood, yet. Some studies even invoked a neuroprotective effect of chalcones [8] [9] .
Previously we disclosed a comparison of the effects of chalcone 1 and its platinum complex 2 on twenty-one tumour cell lines [1] . Now, we present a study of their mechanisms of action and effects in living cells. glutaraldehyde, Glycider 100, propylene oxide, 2,4,6-tris(dimethlyaminomethyl)phenol (Epon; Serva), 0.5% tannic acid (Mallinckrodt), polioform powder, uranyl acetate (Plano, Wetzlar, Germany). The chalcones 1 and 2 were synthesized according to literature [1, 10] . anti-mouse neuron specific III-tubulin (SDL3D10) and goat anti-mouse streptavidin AlexaFluor 488 conjugate (S32354) (Sigma). [12] . Cells were maintained under a moisture-saturated atmosphere (95% humidity, 5% CO 2 ) at 37 °C in 75 mL culture flasks (Nunc, Germany). They were serially passaged using 0.05% trypsin / 0.02% EDTA (PAA Laboratories, Cölbe, Germany).
Media and cell cultures
Inhibition of cancer cell growth (MTT assay)
MTT was used to identify viable cells which reduce it to a violet formazan [15] . 
Cellular uptake of drugs into 518A2 melanoma cells
Routes of uptake of the test compounds were assessed by measuring their cytotoxicity against 
Western blot analysis of organic cation transporters
Cells were collected by centrifugation, suspended in an SDS-PAGE sample buffer, sonicated to shear genomic DNA and boiled at 95 °C for 15 min. The resulting cell suspension was passed through a 27-gauge needle. The combined extracts were separated on a gradient SDS- 
Immunocytochemistry
The cells (518A2 melanoma, astroglia) grown on poly-L-lysine-coated glass cover slips were 
Cell cycle analysis
518A2 melanoma cells (10 6 ) were treated with the test compounds, positive (250 µg/mL nocodazole) / negative (DMF) controls and then harvested at certain time intervals. The cells were washed, re-suspended in 200 µL PBS, and incubated with 8 mL of 70% ice-cold ethanol for fixation. They were centrifuged, washed with PBS, and re-suspended in 1 mL of a PBS solution of 3.8 mM sodium citrate and 50 µg/mL propidium iodide with freshly added RNase [17] . After 1 h incubation at 37 °C the concentration of double-stranded DNA in the samples A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 9 was determined by measuring the emission (570 nm) of its fluorescent adducts excited at 488 nm, using a Beckman CYTOMICS FC 500 cytometer.
Transmission electron microscopy
518A2 melanoma cells were plated on pieces of aclar film, grown for 24 h, exposed for 20 min to 100 µM of either compound 1 or 2 and flat-embedded for transmission electron microscopy as follows. Cells were fixed in 0. transmission electron microscope at 80 kV. Micrographs were taken using EMS EM film.
Results
Cytotoxicity studies with selected cell lines
Neural cells. Chalcones target tubulin and microtubules [19] . We analysed the relative cytotoxicities of chalcones 1 and 2 against tubulin-rich cells of neural origin (Table 1 ; grey rows). Normal mouse astroglia were not particularly sensitive to chalcone 1 and virtually insensitive to platinum complex 2 during the whole 48 h incubation period. However, human U87 glioma cells responded well upon prolonged exposure to both compounds, and especially well to the Pt-complex 2 at an IC 50 (48h) ~ 140 nM. Primary neurons were also sensitive to a prolonged treatment. Both chalcones were strongly cytotoxic against C6 rat glioma cells with IC 50 (48 h) ~ 150-170 nM and also against NE-4C cells derived from the fore-and midbrain vesicles of p53-deficient 9-day-old mouse embryos [20] after exposure for 48 h. WEHI 164 A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11
In order to ascertain whether the chalcone 1 or its platinum complex 2 enter the cell via specific transporters or by endocytosis, a simple temperature-dependent experiment was performed. The process of endocytosis is known to be virtually halted at temperatures below 16 °C [22, 23] . Almost twice as many 518A2 melanoma cells survived exposure to 100 µM of 1 at 4 °C when compared to 37 °C (cf. Supplementary Data), which is an indication of this chalcone being taken up mainly via endocytosis. In contrast, the paused endocytosis process did not affect the cytotoxicity of platinum complex 2, which left ca 40% cells alive at either temperature. Alternative ways for the entry of platinum complexes into cells involve copper related transport proteins (Ctr1) and organic cation transporters (OCT-1/2). Gust et al. studied their relevance by switching off individual transporters with specific inhibitors [24] . Earlier on, the accumulation of cisplatin by a high-affinity copper transporter Ctr1 had been found to compete with that of copper [25] . The OCT convey positively charged substances and may be inhibited by cimetidine (inhibitor) or by tetraethylammonium chloride (TEA; competitor).
Endocytotic processes depending on a sodium gradient can be slowed down by adding ouabaine, an inhibitor of the Na + /K + pump [26] . Macropinocytosis, a distinct form of endocytosis, depends on a Na + /H + exchanger that can be blocked by amiloride [24, 27] . The enzyme phosphatidylinositol 3-kinase that plays a central role in the down-stream signalling cascade associated with macropinocytosis by F-actin microfilament re-arrangement, can be inhibited by the fungal metabolite wortmannin [28] . Clathrine-mediated endocytosis can be blocked by chlorpromazine [29] . We now examined the influence of all these inhibitors on the uptake of chalcones 1 and 2 into 518A2 melanoma cells. To this end, the cells were preincubated with non-toxic concentrations of the respective inhibitors for 15 min before the chalcones were added and their cytotoxicities were measured by the usual MTT assay. ( (Figure 2 here)) 
Western blot analysis of organic cation transporters
Evidence for the presence in 518A2 melanoma and KBv1 +Vbl cervix carcinoma cells of organic cation transporters hOCT-1 and hOCT-2 that belong to the solute carrier subfamily SLC22A of membrane transport proteins was provided by westernblotting. More than one band were visible upon staining with a primary antibody for hOCT-1 (= SLC22A1) since it recognises the N-terminus of this protein which is a highly conserved segment also present in OCT-2. In addition, several isoforms of hOCT-1 are known. We could assign the band corresponding to a protein of size ~54 kDa to hOCT-1. Staining of the membrane with an antibody specific for the C-terminus of hOCT-2 (= SLC22A2), which differs considerably from the C-terminus of hOCT-1, rendered a single intense band for this protein of size ~30
kDa. This band had also been visible upon staining with the less specific OCT-1 antibody.
Although the abundance of hOCT-1/2 in tumour cells in general had been frequently proposed [30] , this is the first experimental evidence for their occurrence in the said two cancer cell lines.
( (Figure 3 here)) 
Interference with ABC transporters
We investigated whether chalcones 1 and 2 interact with drug transport proteins of types ABCB1 (P-gp) [31] [32] [33] or BCRP [34] in a substrate-or inhibitor-like fashion. P-gp overexpressing KBv1 +Vbl cervix carcinoma cells [35] alongside their wild type parent cells were treated with chalcones 1 and 2 in the presence of calcein-AM (Fig. 4a) . (( Figure 4 here)) 
Time-lapse microscopy
Neurons are particularly rich in tubulin and so are well suited to test agents affecting microtubule organisation. Their regular growth requires microtubules being transported plus ends first from the cell body all the way down into the axon [40] . The effect of chalcones 1 and 2 on the structure, development and movement of a network of rat neurons was now A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 15 monitored by time-lapse microscopy [41] . Neurons treated with 10 µM of the test compounds showed a retraction of their processes back to the soma within 30 minutes (Fig. 5, top) (( Figure 5 here)) 
Immunocytochemistry of actin filaments in astrocytes and 518A2 cells
An immunocytochemical analysis of the morphological changes of the actin filaments of astrocytes initiated by the chalcones 1 and 2 was carried out and compared with the behaviour of 518A2 melanoma cells. Antibodies to astrocyte-specific GFAP intermediate filaments (glial fibrillary acidic protein) were employed to visualise the astroglial cells and phalloidin labelling was used to identify actin filaments. The micrographs showed that both types of filaments, actin (in green) and GFAP (in red), were disintegrated upon treatment with the test chalcones, most pronouncedly the actin filaments near the cell membrane. The GFAP filaments shrank only in the vicinity of the cell nuclei, which remained unaffected. Figure 6 shows typical effects of chalcone 1 on astrocytes. Results with complex 2 were similar.
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Likewise, fluorescence micrographs of immunostained 518A2 cells revealed a significant breakdown of the actin network when treated with chalcones 1 or 2 (Fig. 7) .
(( Figures 6 and 7 here)) 
Cell cycle analysis
While cisplatin is known to generally arrest cells in the G1 phase due to cross-link interaction with DNA [42] chalcone, 1,3-diphenylpropenone, arrests cells of the human T24 and HT-1376 bladder cancers in the G2/M phase [43] . We now assessed the cell cycle progression of melanoma 518A2 cells treated with chalcones 1 and 2 by FACS analysis after DNA staining with propidium iodide ( To dismiss a conceivable hydrolytic cleavage of 2 during incubation, we also proved that 100 µM of dichlorido(6-aminomethylnicotinic acid)platinum(II), the assumed hydrolysis product of ester 2, had no effect on the cell cycle at all. As a positive control, treatment with cisplatin led to 69% of 518A2 cells being arrested in G1 phase.
( (Figure 8 here)) 
Transmission electron microscopy
For a visualisation of morphological effects 518A2 melanoma cells were treated with 100 µM 1 or 2 for 15 min, kept under medium for another hour, then embedded and finally viewed with a transmission electron microscope (TEM). While untreated control cells appeared prolate and undifferentiated with filopodia for cell attachment on the rim, the cells incubated 17 with the chalcones 1 or 2 adopted a rounded shape. A similar morphological change had been reported for H460 non-small cell lung cancer cells treated with CA4 [44] . In addition, the treated 518A2 cells had blebs emerging on their surface (cf. Supplementary Data). Stress fibres were also observed in the treated cells (Fig. 9h) . Multivesicular bodies and autophages ( Fig. 10b) with double membranes were visible in most of the analysed cells (Fig. 9f) . Control cells and treated cells also differed with respect to the state of their mitochondria, centrioles and Golgi apparatus (GA). Mitochondrial populations consist mainly of short and long tubules, which constantly migrate along microtubule tracks [45] . Any disruption of the microtubules/actin skeleton, e.g., by treatment with chalcones 1 or 2 should severely affect the mitochondrial trafficking and cause mitochondrial disorganisation. We found that mitochondria of cells treated with the chalcones were highly condensed and localised mainly at the apical side of the cells. They frequently displayed dislocated inner membranes (Fig. 9e) .
Only a small percentage of the untreated control cells were found in G2/M phase with visible centrioles. After treatment with the chalcones, many cells had visible pro-centrioles (Fig. 9c) , which is an indication of them being arrested in G2/M phase. The GA undergoes irreversible fragmentation during apoptosis in part as a result of caspase-mediated cleavage of several Golgi-associated proteins. A fragmentation of the GA was observed mainly in 518A2 cells treated with complex 2 (Fig. 10b) but not with chalcone 1.
(( Figures 9 and 10 here))
Discussion
The in vitro cytotoxicities of the chalcones While chalcone 1 is preferentially accumulated by endocytosis its platinum complex 2 is taken up mainly via the organic cation and copper related transporters. Insofar, complex 2 resembles oxaliplatin which was shown by Lippard et al [46] to be an excellent substrate for the human organic cation transporters OCT-1 and OCT-2. Both chalcones 1 and 2 vigorously depolymerised microtubules and actin filaments in neural and cancer cells. They proved equally effective in damaging mitochondria and in arresting cancer cells in G2/M phase.
However, only complex 2 led to an accumulation of cells in G1 phase, reminiscent of the effect of cisplatin. Hence, complex 2 has a dual impact on the cell cycle of 518A2 melanoma cells by combining the effects of Pt-complexes and of chalcones in general. However, the DNA binding activity of 2 was found to be four times lower than that of the good DNAbinder cisplatin [1] . This could explain the lower number of cells arrested in G1 phase upon treatment with 2. Morphologically, both test compounds led to a rounding and detachment of 518A cells and an enhancement of their motility and cell shrinking dynamic. This behaviour is in line with the generally accepted mechanisms of tubulin binding agents (TBAs) [3] involving activation of RhoA/RhoA kinase, an intracellular coordinator of cytoskeletal rearrangement of microtubules and actin. In our experiment with 1 and 2, 518A2 cells were able to repair the shrinkage effects and most of them spread again after three hours. The results from the transmission electron microscopy of 518A2 cells treated with the compounds 19 a result of aberrant chromosome segregation could be due to DNA damage (possibly in tandem with defective checkpoints) or to a destabilisation of the spindle apparatus [44, 47] .
Maintenance of the microtubule integrity plays a pivotal role in stabilising the pericentriolar matrix. Our observation is consistent with the notion that the microtubule depolymerising effect of both chalcones 1 and 2 leads to a mitotic catastrophe and thus to an arrest in G2/M phase. A similar mitotic failure had been reported for H460 NSCLC cells treated with CA4 [44] . Moreover, complex 2 but not chalcone 1 initiated the fragmentation of the Golgi apparatus of 518A2 melanoma cells. This fragmentation is an early event that occurs independently of major changes to the actin and tubulin cytoskeleton [48] .
Thus, the observed differences in the anticancer activities of the free chalcone 1 vs. its platinum complex 2 could be traced back to distinct differences in the biochemistry of their uptake, clearance and impact on the cell cycle and on cellular components. Complex 2 apparently combines some modes of action of chalcones and platinum complexes and so can address more cancer-relevant targets than parent chalcone 1.
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